Overview

Study of Nivolumab for Advanced Cancers in India

Status:
Completed
Trial end date:
2019-07-17
Target enrollment:
Participant gender:
Summary
This is a study of nivolumab in participants with advanced Non-Small Cell Lung Cancer or Kidney Cancer in India.
Phase:
Phase 4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Antibodies, Monoclonal
Nivolumab